Literature DB >> 12244003

Early airway infection, inflammation, and lung function in cystic fibrosis.

G M Nixon1, D S Armstrong, R Carzino, J B Carlin, A Olinsky, C F Robertson, K Grimwood, Claire Wainwright.   

Abstract

AIMS: To determine the relation between lower airway infection and inflammation, respiratory symptoms, and lung function in infants and young children with cystic fibrosis (CF).
METHODS: A prospective study of children with CF aged younger than 3 years, diagnosed by a newborn screening programme. All were clinically stable and had testing as outpatients. Subjects underwent bronchial lavage (BL) and lung function testing by the raised volume rapid thoracoabdominal compression technique under general anaesthesia. BL fluid was cultured and analysed for neutrophil count, interleukin 8, and neutrophil elastase. Lung function was assessed by forced expiratory volume in 0.5, 0.75, and 1 second.
RESULTS: Thirty six children with CF were tested on 54 occasions. Lower airway infection shown by BL was associated with a 10% reduction in FEV(0.5) compared with subjects without infection. No relation was identified between airway inflammation and lung function. Daily moist cough within the week before testing was reported on 20/54 occasions, but in only seven (35%) was infection detected. Independent of either infection status or airway inflammation, those with daily cough had lower lung function than those without respiratory symptoms at the time of BL (mean adjusted FEV(0.5) 195 ml and 236 ml respectively).
CONCLUSIONS: In young children with CF, both respiratory symptoms and airway infection have independent, additive effects on lung function, unrelated to airway inflammation. Further studies are needed to understand the mechanisms of airway obstruction in these young patients.

Entities:  

Mesh:

Year:  2002        PMID: 12244003      PMCID: PMC1763045          DOI: 10.1136/adc.87.4.306

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  36 in total

1.  Ventilatory function in infants with cystic fibrosis. Physiological assessment of halation therapy.

Authors:  P D Phelan; M Gracey; H E Williams; C M Anderson
Journal:  Arch Dis Child       Date:  1969-06       Impact factor: 3.791

2.  Airway function in infants newly diagnosed with cystic fibrosis.

Authors:  S C Ranganathan; C Dezateux; A Bush; S B Carr; R A Castle; S Madge; J Price; J Stroobant; A Wade; C Wallis; J Stocks
Journal:  Lancet       Date:  2001-12-08       Impact factor: 79.321

3.  Respiratory mucous secretions in patients with cystic fibrosis: relationship between levels of highly sulfated mucin component and severity of the disease.

Authors:  K V Chace; D S Leahy; R Martin; R Carubelli; M Flux; G P Sachdev
Journal:  Clin Chim Acta       Date:  1983-08-15       Impact factor: 3.786

4.  Bronchial mucous glands in the newborn with cystic fibrosis.

Authors:  C W Chow; L I Landau; L M Taussig
Journal:  Eur J Pediatr       Date:  1982-12       Impact factor: 3.183

5.  Comparison of lung function in infants exposed to maternal smoking and in infants with a family history of asthma.

Authors:  S Sheikh; L J Goldsmith; L Howell; L Parry; N Eid
Journal:  Chest       Date:  1999-07       Impact factor: 9.410

Review 6.  Lung function testing in infants with cystic fibrosis: lessons from the past and future directions.

Authors:  M Gappa; S C Ranganathan; J Stocks
Journal:  Pediatr Pulmonol       Date:  2001-09

7.  Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis.

Authors:  J P Gutierrez; K Grimwood; D S Armstrong; J B Carlin; R Carzino; A Olinsky; C F Robertson; P D Phelan
Journal:  Eur Respir J       Date:  2001-02       Impact factor: 16.671

8.  Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis.

Authors:  Carolyn J Dakin; Andrew H Numa; He Wang; John R Morton; Calypso C Vertzyas; Richard L Henry
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

9.  Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  G M Nixon; D S Armstrong; R Carzino; J B Carlin; A Olinsky; C F Robertson; K Grimwood
Journal:  J Pediatr       Date:  2001-05       Impact factor: 4.406

10.  Serial lung function studies in cystic fibrosis in the first 5 years of life.

Authors:  S Godfrey; M Mearns; G Howlett
Journal:  Arch Dis Child       Date:  1978-01       Impact factor: 3.791

View more
  24 in total

1.  Respiratory syncytial virus pathophysiology and affect of palivizumab in special populations: cystic fibrosis and immunosuppression.

Authors:  Michael E Speer
Journal:  J Pediatr Pharmacol Ther       Date:  2011-04

2.  Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.

Authors:  Edith T Zemanick; Brandie D Wagner; J Kirk Harris; Jeffery S Wagener; Frank J Accurso; Scott D Sagel
Journal:  Pediatr Pulmonol       Date:  2010-06

3.  Is limited computed tomography the future for imaging the lungs of children with cystic fibrosis?

Authors:  S C Langton Hewer
Journal:  Arch Dis Child       Date:  2006-05       Impact factor: 3.791

Review 4.  New insights into pulmonary inflammation in cystic fibrosis.

Authors:  S Rao; J Grigg
Journal:  Arch Dis Child       Date:  2006-09       Impact factor: 3.791

Review 5.  Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Authors:  Olivia Giddings; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2017-07-17

6.  What and when to collect from infants with cystic fibrosis.

Authors:  Iolo Doull
Journal:  Arch Dis Child       Date:  2007-10       Impact factor: 3.791

7.  Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis.

Authors:  J Kirk Harris; Mary Ann De Groote; Scott D Sagel; Edith T Zemanick; Robert Kapsner; Churee Penvari; Heidi Kaess; Robin R Deterding; Frank J Accurso; Norman R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

8.  Methylomic correlates of autophagy activity in cystic fibrosis.

Authors:  Kyle Caution; Alexander Pan; Kathrin Krause; Asmaa Badr; Kaitlin Hamilton; Anup Vaidya; Hawin Gosu; Kylene Daily; Shady Estfanous; Mikhail A Gavrilin; Mark E Drew; Estelle Cormet-Boyaka; Xi Chen; David E Frankhouser; Ralf Bundschuh; Pearlly Yan; Duaa Dakhlallah; Amal O Amer
Journal:  J Cyst Fibros       Date:  2019-02-06       Impact factor: 5.482

Review 9.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

10.  Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study.

Authors:  Stefanie Hennig; Ross Norris; Carl M J Kirkpatrick
Journal:  Br J Clin Pharmacol       Date:  2007-11-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.